A new vaccine being developed by scientists in Austria is effective against all SARS-CoV-2 variants known to date, including Omicron, even in those who have not yet built up any immunity as a result of immunisation, according to the preclinical data. The antigen-based vaccine developed at MedUni Vienna targets the receptor binding domains (RBD) of … Read more
The research, recently published in the journal Allergy, found that only individuals vaccinated with a third or booster dose of the COVID-19 vaccine form antibodies that can partially block Omicron. People who are double-vaccinated and those who have recovered from infection by previous strains of the SARS-CoV-2 virus have virtually no antibody protection against the … Read more
The coating, described in the journal ACS Applied Materials & Interfaces, may be used in future to develop an antiviral spray for fabrics. Scientists in the US have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of SARS-CoV-2, the virus that causes COVID-19, by up to 90 per cent. The … Read more
The more people infected with the virus, the more are the chances of random mutations. By Rajneesh Bhandari The pandemic has added words like “spike protein, delta variant, mutation etc.” to our household vocabulary, and now we have a new phrase, “Delta plus,” on the horizon. A mutation is a change in the genome sequence … Read more